by scmrdev | Mar 22, 2017
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), which regulates pharmaceuticals in the EU, has recommended (link) “the suspension of the marketing authorizations for four linear gadolinium contrast agents because of... by scmrdev | Mar 22, 2017
Circulation Research. 2017;120:995-1014 Link: http://circres.ahajournals.org/content/120/6/995.long Multimodality cardiovascular imaging plays a central role in caring for patients with congenital heart disease (CHD). CHD clinicians and scientists are interested not... by scmrdev | Feb 27, 2017
N Engl J Med. 2017 Feb 23;376(8):755-764 Link: http://www.nejm.org/doi/full/10.1056/NEJMoa1603265 Background The presence of a cardiovascular implantable electronic device has long been a contraindication for the performance of magnetic resonance imaging (MRI). We... by scmrdev | Feb 21, 2017
Visit the Journal of Cardiovascular Magnetic Resonance to read full article. Background With multifaceted imaging capabilities, cardiovascular magnetic resonance (CMR) is playing a progressively increasing role in the management of various cardiac conditions. A global... by scmrdev | Feb 15, 2017
Journal of the American College of Cardiology Feb 2017, 69 (7) 761-773 Link: http://www.onlinejacc.org/content/69/7/761?utm_medium=email_newsletter&utm_source=jacc&utm_campaign=toc&utm_content=20170213&rss=1 Background A previously under-recognized subset of... by scmrdev | Jan 25, 2017
Csepe TA et al. Link: http://ehjcimaging.oxfordjournals.org/content/early/2017/01/13/ehjci.jew304.long The adult human sinoatrial node (SAN) has a specialized fibrotic intramural structure (35-55% fibrotic tissue) that provides mechanical and electrical protection... by scmrdev | Jan 18, 2017
J Cardiovasc Magn Reson. 2017 Jan 13;19(1):1. Liu A et al Link: https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-016-0318-2 Background: Perfusion cardiovascular magnetic resonance (CMR) performed with inadequate adenosine stress leads to false-negative...
